UBS analyst Michael Leuchten upgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Neutral to Buy on 'Much Cleaner Pro-Forma Profile'.
https://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+AstraZeneca+%28AZN%3ALN%29+%28AZN%29+to+Buy+on+Much+Cleaner+Pro-Forma+Profile/18030620.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.